Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REZAFUNGIN vs RIFAMPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REZAFUNGIN vs RIFAMPIN: Safety Overview

Metric REZAFUNGIN RIFAMPIN
Total FAERS Reports 108 13,347
Deaths Reported 12 1,439
Death Rate 11.1% 10.8%
Hospitalizations 20 5,764
Average Patient Age 53.8 yrs 51.7 yrs
% Female Patients 54.3% 47.8%
FDA Approval Date Mar 22, 2023 Approved Prior to Jan 1, 1982
Manufacturer Melinta Therapeutics, LLC Hikma Pharmaceuticals USA Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued